Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus.
about
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicCurrent concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococciTargeting Antibiotic ResistanceSafety profiles of old and new antimicrobials for the treatment of MRSA infections.Effect of ceftaroline on normal human intestinal microflora.Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Pulmonary Exacerbation in a Pediatric Cystic Fibrosis PatientCeftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.New drugs approved in 2010In vitro activity of ceftaroline against gram-positive and gram-negative pathogens isolated from patients in Canadian hospitals in 2009.Ceftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA)Pre-Use Susceptibility to Ceftaroline in Clinical Staphylococcus aureus Isolates from Germany: Is There a Non-Susceptible Pool to be Selected?[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].Reversing resistance: The next generation antibacterials.Ceftaroline in complicated skin and skin-structure infections.Pharmacokinetics of ceftaroline in normal body weight and obese (classes I, II, and III) healthy adult subjectsClinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumoniaIn vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance studyEmerging drugs in sepsis.Ceftaroline fosamil: a new broad-spectrum cephalosporin.Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.Antibiotic resistance in Enterococcus faecium clinical isolates.A critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of ceftaroline.Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination.Ceftazidime-avibactam: novel antimicrobial combination for the treatment of complicated urinary tract infections.Efficacy, pharmacokinetic and pharmacodynamic profile of ceftolozane + tazobactam in the treatment of complicated urinary tract infections.Recent Advances in the Rational Design and Optimization of Antibacterial Agents.Acute bacterial skin and skin structure infections: current perspective.Outpatient use of ceftaroline fosamil versus vancomycin for osteoarticular infection: a matched cohort study.Novel antibiotics for the treatment of Staphylococcus aureus.Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.Identification, synthesis and biological activity of alkyl-guanidine oligomers as potent antibacterial agents.Modulation of the antibiotic activity against multidrug resistant strains of 4-(phenylsulfonyl) morpholine.Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity.Ceftaroline fosamil: A novel anti-Methicillin-resistant Staphylococcus aureus cephalosporin.Analysis of Potential β-Lactam Surrogates to Predict In Vitro Susceptibility and Resistance to Ceftaroline for Clinical Isolates of Enterobacteriaceae.
P2860
Q24614464-5C482D1E-5D8E-42B3-A3D4-F1DF28F9414AQ26853465-A841CCE5-B122-4F1E-B33A-2CF6F608B10EQ28078130-70102DA8-CA33-4EFB-A043-FB54440464CEQ33429168-7D1FF00B-5512-4EA6-A862-1F25214176C8Q33826455-F7E2999D-B95B-49CE-8F3F-7DFAA562B7F4Q33886807-C55625FF-3CAB-4CA4-A198-215FDB22183CQ34325573-5E4F5E44-676A-4A23-9309-01CC0EBACEDAQ34393008-C23D7EA1-8593-42CF-9522-95E736B42268Q34753085-E431822D-CAB4-4F61-932D-B6C92A7707BBQ35004919-F449F288-2792-46E0-B56E-FFCD8872D827Q35117981-2257BD03-6B9A-4996-A3DA-97E5C45ABCC0Q35587135-BA3543CD-7156-4A91-8647-6B2C523C3EEBQ35619094-CB4A2AC5-088A-4637-953C-F492B2914233Q35669688-A337F1E1-581D-4F30-BAA5-1B45E127B109Q35715381-0C1A4350-34D9-4AA1-925F-DB67A03DEC6CQ35746176-B13C342D-6A7E-4BD5-B94E-1DBAC1FB21E9Q35752997-E272B196-6CC6-4471-8D27-127CE676124EQ37263425-6E5BE1A6-7F08-4F13-A851-191376945D77Q37670186-5E3A6A5A-9586-4414-9BE3-C67E40AA8AF3Q37863942-C0574A3C-71FA-414A-B20C-7B77C5A7D9ABQ38025132-49AE6246-CB05-424F-911B-B0CD04F13797Q38117077-C80D2DD3-5C87-4D22-8F3A-616FB40708B2Q38176042-B0779D75-5BD0-4624-B4AA-5343E6D74E28Q38458802-611BD094-27F0-4AC9-AFB9-159E153F7844Q38544744-88F85E97-1658-4534-A68F-5FCACE4372F5Q38740494-C293C870-AC53-4AC7-BA84-83A810573A2BQ38872130-2D4D520A-9431-4A71-8DDC-E1595E75F85DQ38958278-4D706743-30DD-45DA-AFC4-9A254FC3EBD1Q39268884-3F5CBBE0-A4CB-4572-9536-9D5B3E205D33Q39484611-20619308-3554-4322-8A6F-D9ECFBEB2E46Q39933945-2B92CF0A-24F7-44D9-BA7B-B86518CC2CD6Q40224839-C8C94EA2-EDD1-46D9-B426-9CB2DD95CC39Q40335746-E8D97DDB-162A-4246-958B-EE3E402B1B5CQ41423430-F50B2640-783D-41F2-AF9B-4AB8F8DDDF1CQ41767336-7BA62696-9284-4FE7-B258-342292BD0033Q42790618-D0C53CA6-4896-4275-B092-DFC7E7D481E1Q42869521-AFAB429B-53A3-49CA-B063-64ECD34F2070Q50048535-D6800EE8-AC19-4A30-9D00-F37DC6147B77
P2860
Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.
@ast
Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.
@en
Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.
@nl
type
label
Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.
@ast
Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.
@en
Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.
@nl
prefLabel
Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.
@ast
Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.
@en
Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.
@nl
P2093
P50
P1433
P1476
Ceftaroline: a novel broad-spe ...... esistant Staphylococcus aureus
@en
P2093
Alfred S Gin
Daryl J Hoban
Ethan Rubinstein
Frank Schweizer
Grace Sniezek
James A Karlowsky
P304
P356
10.2165/00003495-200969070-00003
P577
2009-01-01T00:00:00Z
P6179
1028367278